How the COVID-19 pandemic affects transgender health care in upper-middle-income and high-income countries – A worldwide, cross-sectional survey

Introduction

Transgender people experience their gender as incongruent with the sex assigned at birth. They might identify as a binary gender (female, male) or outside of the gender binary. People who are non-binary might experience their gender as moving between male and female (e.g., genderfluid) or as situated beyond the gender binary (e.g., genderqueer). Some reject the concept of sex and gender at all, either on a personal, or a general level (e.g., agender). Transgender health care primarily focusses on medical measures to support the person’s transition to live their gender both physically and socially. This may include hormone therapy, gender-affirming surgery, and a variety of additional interventions (e.g., voice and communication therapy, hair removal)[1]. For treatment-seeking transgender people these interventions positively affect mental health and quality of life, and are thus considered state-of-the-art treatments [2-5]. However, not all transgender people want to undergo any of these types of care, or might have access to it [6, 7].

Up to now, transgender people have been considered to be a vulnerable social group, many of whom have experienced discrimination and marginalization by society, and health care systems in particular [4, 8]. Access to transgender health care is often restricted due to legal requirements, financial barriers, and ‘gatekeeping’ health care providers in countries all over the world [9, 10]. These elements can lead to a negative impact on transgender individual’s health and quality of life [4].

During to the COVID-19 pandemic access to medical care was, and in some areas globally still is, restricted for nearly all non-acute medical conditions. State health care, as well as private practice, were mainly focusing on COVID-19. Since transgender individuals often need access to medical treatments such as hormone therapy [1], these restrictions are likely to have increased psychological distress. Due to both their status as a vulnerable social group and their need for transition-related treatments [4, 8], this impact may be particularly severe for transgender people [11].

Even though some authors have already addressed the impact of the COVID-19 pandemic on transgender people, there remains a dearth of evidence. Perez-Brumer and Silva-Santisteban [12] discussed the disparities transgender people face in Peru due to binary-based policies as a response to the COVID-19 pandemic (only women or men are allowed to leave their homes on certain weekdays) and how this increasing discrimination impacts physical and mental health. Van der Miesen and colleagues [13] summarized the intersections between health care, human rights, and socioeconomic stress for transgender individuals during the COVID-19 pandemic. They state the need for a joint strategy of policy makers, transgender advocates, health care providers, and governments. Wang and colleagues [11] refer to the barriers of care for transgender people in times of COVID-19 in light of evidence from their clinic in Beijing, China. The restricted access to hormone treatment was associated with high levels of depression and anxiety due to the challenge of continuing presenting and socially living as their sex assigned at birth. All the authors state the need for collaborative strategies between relevant stakeholders (e.g., governments, health care providers, advocacy groups) to actively consider the difficulties faced by the transgender population during the COVID-19 pandemic and the need for high-quality evidence to base strategies upon [11-13].

Therefore, as the first of its kind, the current study systematically investigates the impact of the COVID-19 pandemic on the health and health care of transgender individuals. As an ad hoc collaboration between researchers, community members and clinicians from several countries, it aims to generate empirical evidence on the situation of transgender individuals in times of COVID-19 and, therefore, help to develop and implement measures addressing the obstacles that affect transgender individuals during the pandemic.

Methods

Results

Between May 1, 2020, and August 9, 2020, 7905 potential participants accessed the survey. 597 participants did not give informed consent and thus were not able to access the survey. Another 593 participants gave informed consent but did not answer any further questions. From the remaining 6715 participants, 1223 individuals were excluded from the analyses because they did not respond to at least 50% of the survey. For the present analysis, 225 participants from low-income and lower middle-income economies were not included. The final dataset consisted of 5267 participants.

On average, the present sample is of early middle age (30.70 years ± 12.06), highly educated (60.7% tertiary education), mostly single (48.7%), and living in an urban environment (79.9%). 57.3% were assigned female at birth. 74.0% identified as binary [trans] man or [trans] woman, whereas 21.5% identified as a non-binary gender.

Basic and transgender-related demographics are presented in Table 1. Table 2 and Fig 1 show the current country of residence of the participants.[14] Most participants lived in European countries. Fig 2 gives an overview of the physical health problems of the participants. 2768 (52.6%) reported a least one acute or chronic condition. 525 (10.0%) reported that these conditions resulted in severe limitations in daily activities, 1674 (31.8%) reported limitations to some extent. 509 (9.7%) had no limitations due to their chronic condition. 1009 (19.2%) of the participants were smokers. 327 (6.2%) used to smoke but had recently stopped. 3035 (73.6%) had at least once in their life seriously considered suicide, 1827 (35.1%) had had suicidal thoughts since the beginning of the COVID-19 pandemic. 1797 (34.5%) had had at least once suicide attempt, 168 (3.2%) have attempted suicide since the beginning of the COVID-19 pandemic.

• Download figure
• Open in new tab

Fig 1.

Participants current country of residence

• Download figure
• Open in new tab

Fig 2.

Acute and chronic conditions associated with a risk of a severe course of a COVID-19 infection

Table 3 gives an overview on COVID-19-related topics. Participants were quite satisfied with the information they received on the COVID-19 pandemic (M: 2.13 ± 0.8) and had high confidence in medical personnel to diagnose COVID-19 (M: 2.01 ± 0.8). Participants assumed it as not very likely to be diagnosed with COVID-19 (M: 2.90 ± 0.9) and as highly likely to survive a COVID-19 infection (M: 1.63 ± 0.8). They were concerned that members of their families or close friends will contract COVID-19 (M: 2.09 ± 0.9).

Table 4 summarises the influence of the COVID-19 pandemic on transgender health care. Of the 4699 participants that had undergone transition-related treatment or planned to do so, 2875 (61.2%) feared access restrictions to transgender health care in the future due to the COVID-19 pandemic. Of the 3463 participants that had already undergone transition-related treatment, 1706 (49.3%) experienced restrictions in access to transgender health care services. A multivariate logistic regression analysis revealed that the sex assigned at birth and the adequacy of the monthly income predicted the experience of restrictions to transgender health care significantly. Participants assigned male at birth (OR: 2.239) and individuals with a lower income (OR: 1.102) were at greater risk of experiencing restrictions to transgender health care procedures (Table 5).

Discussion

As the first of its kind, the current study provides empirical insights into how the COVID-19 pandemic affects the health care of transgender people in higher middle-income and high-income countries. Over 50% of our participants had risk factors for a severe course of a COVID-19 infection and were at a high risk of avoiding testing or treatment of a potential COVID-19 infection due to fear of mistreatment and/or discrimination. Transgender health care was highly affected by the COVID-19 pandemic, with almost half of participants experiencing some sort of restricted access to health care. Restricted access to transgender health care applied rather universally to all transgender individuals, with a male sex assigned at birth and a lower monthly income as the only significant predictors.

We found, that over 50% of transgender individuals have risk factors for a severe course of a COVID-19 infection (i.e., pre-existing medical conditions, being a smoker).[19-22] Compared with that, 23.5% of the working population in the EU and one-third of the European general population over 15 suffer from chronic conditions [23]. Similar numbers were found for other OECD countries [24]. Only in the US is the prevalence of chronic conditions between the transgender and the general population approximately equal, with 6 out of 10 adults having a chronic condition [25]. Additionally, our participants were likely to avoid COVID-19 testing or care because of fears of discrimination or mistreatment. This was true even though they were aware of the potential severity of COVID-19. This avoidance of care could even worsen their risk for serious consequences of COVID-19.

We found that access to all transgender health care interventions was restricted due to the COVID-19 pandemic. This could be especially important for those who access ongoing treatments such as hormone therapy [3]. Hormone therapy is considered one of the most important treatment options for many transgender individuals and is highly associated with better mental health and quality of life [26]. An interruption of a hormone therapy is not associated with physical risks when gonadectomy was not performed. However, mental health risks must be considered. Stopping hormone treatment is often associated with a return of some features related to the sex assigned at birth (e.g., the return of menstruation). Moreover, mood swings and symptoms of depression and anxiety can occur [2, 3, 27]. There is a risk of psychological distress for the twenty percent of our sample whose hormones have been, or still are, restricted due to the pandemic. This association has also been reported by Wang and colleagues in their clinic in Beijing, China [11]. The same may well be true for hair removal treatments. While hair removal might not have the same value as hormone treatment, it is often performed as a supportive measure as hormone treatment alone could be insufficient to eliminate hair growth [27]. As a population, transgender individuals are already experiencing poor mental health, decreased quality of life, and are at high risk of discrimination and harassment [4, 8]; consequently, the restrictions in access to health care may affect transgender people to a greater extent than the general population. This higher vulnerability might also intersect with other minority statuses, such as being a person of colour.

All these transgender-specific issues caused by the COVID-19 pandemic need to be addressed by both structural changes as well as counselling services (e.g., peer counselling) and mental health care professionals. However, due to the COVID-19 pandemic, access to these measures is limited, too. For 43.4% of the participants who assessed counselling services, the access to those was restricted. 61.9% of those who undergo mental health care (e.g., for a pre-existing affective disorder) experienced access restrictions. Only half of the participants had alternative options for accessing counselling services (e.g., online consultations). Additionally, even access to low-threshold services, like support groups, was limited for two thirds of their members. In light of the available data, the COVID-19 pandemic and its associated restrictions, combined with the systemic inequalities transgender people face in almost every country in the world, appears to have had a significant impact on the (mental) health of transgender people. Tragically, our study found that more than one third of our sample had had suicidal thoughts and 3.2% had attempted suicide since the beginning of the pandemic. And even though no causal conclusions can be drawn based on our cross-sectional study, it seems reasonable to assume that many of these suicidal attempts are linked to the situation caused by the COVID-19 pandemic. Indeed, at the least this association ought to be a warning sign that transgender people might be disproportionally affected by COVID-19.

Some treatment options for transgender people such as genital surgeries [1] have been highly restricted due to the COVID-19 pandemic, too. At the time of the data analysis, approximately 15.6% of surgeries were already cancelled and another 19.5% of the participants expected their surgery to be cancelled. Additionally, aftercare for recent surgery was also restricted. As genital surgery is considered an important treatment option to increase quality of life and reduce psychological distress in transgender people [2, 28], a postponement of these procedures can negatively impact a person’s well-being. Especially regarding surgical aftercare, restrictions could lead to serious health concerns like wound infections or disorders of wound healing [2]. Moreover, due to insecurities caused by the postponement of surgery, mental health problems could occur which should be addressed by counselling services or mental health professionals when possible. However, as the access to these services is restricted too, problems associated with postponed surgeries might not be addressed sufficiently and could intersect with already existing distress such as restrictions to accessing hormone treatment.

All potential distress caused by restrictions to transgender health care might be further affected by social and socio-economic circumstances, as already reported by Perez-Brumer and Silva-Santisteban [12]. We found that one third of our participants had difficulties making ends meet with their available monthly income and another third experienced distress due to their current living situation. However, using regression analysis, we only found a male sex assigned at birth and a lower monthly income to be significant predictors for the experience of restrictions to transgender health care. The significant association to a male sex assigned at birth could be due to a greater stigma towards transgender people assigned male at birth [29]. The association between the monthly income and a higher risk of restrictions to transgender health care with an OR of 1.102 could be considered weak. Therefore, it seems that the COVID-19 pandemic hits the transgender population in higher-middle-income and high-income countries in its entirety and that there aren’t any major protective social factors.

The strength of our study is that it includes a high number of participants from several countries all over the world. This is important as, with a number of 6.8 to 355 per 100,000, transgender people are only a small group within the general population [30]. The results are therefore likely to be applicable to other upper middle-income and high-income countries with similar health systems. Moreover, the study was developed and conducted by transgender researchers in close cooperation with community organisations. Therefore, we intentionally took power differences between researchers and study subjects into account and tried to ensure tangible outcomes for the community.

We consider the type of data collection a potential limitation of our study due to access to the internet being a necessity. This could have excluded participants with low income or without experience with digital technology. However, our sample was comparable to previous studies, in terms of gender or education, for example [7, 18]. As there is still a dynamic COVID-19 situation, with increasing and decreasing numbers of infections and changing national measures to address these, this research also did not explore international comparisons. In countries where COVID-19 has been more effectively suppressed the impacts of COVID-19 could, therefore, be lower. Moreover, we only analysed data from higher middle-income and high-income countries, which is why the results cannot be generalized to countries with lower GNI per capita. However, as participant recruitment in lower middle-income countries and low-income countries appeared to be difficult (but is still ongoing) the clear need for evidence of how COVID-19 affects transgender people led us to focus on the present data. We currently strive to provide data from lower middle-income countries and low-income countries as soon as possible.

In sum, it appears that the COVID-19 pandemic has an extraordinary impact on the transgender population in higher middle-income and high-income countries, and that transgender people might suffer under the severity of the pandemic even more than the general population. This is due to the intersections between their status as a vulnerable social group, their high amount of medical risk factors, and their need for ongoing medical treatment. The COVID-19 pandemic can potentiate these vulnerabilities, add new challenges for transgender people, and can therefore lead to devastating consequences such as severe physical or mental health issues, self-harming behaviour, and even suicidality.

Funding

The author(s) received no specific funding for this work.

Contributors

XX, YY, and ZZ conceived the study. All authors reviewed the study concerning country-specific issues. All authors contributed to participant recruitment and data collection. XX, YY, and ZZ managed the data and did the statistical analysis. All authors collaborated in interpretation of the results and drafting and revision of the manuscript.

Declaration of Interests

All authors declare no competing interests.

Data sharing

We will consider sharing de-identified, individual participant-level data that underlie the results reported in this Article on receipt of a request detailing the study hypothesis and statistical analysis plan. All requests should be sent to the corresponding author. The corresponding author and lead investigators of this study will discuss all requests and make decisions about whether data sharing is appropriate based on the scientific rigour of the proposal. All applicants will be asked to sign a data access agreement.